Background and objectives: Vitamin D and its metabolites act through vitamin D receptor (VDR). We hypothesized that subjects with low serum 25(OH)D levels but normal PTH might have increased VDR expression. Design and Methods: VDRmRNA expression was assessed by real time PCR in duodenal mucosa and PBMC (peripheral blood mononuclear cells) in 45 subjects with normal duodenoscopy and in PBMC alone in 48 healthy volunteers with hypovitaminosis D. 25(OH)D, PTH and VDRmRNA expression in PBMC was reassessed after 8 weeks of oral cholecalciferol (60 000 IU per week) in a subset (n ¼ 23) of healthy volunteers. Results and Conclusions: The VDRmRNA expressions in the duodenum and PBMC were significantly correlated (r ¼ 0.42), but the expression was 13 times higher in the former than the latter. The mean VDRmRNA expression was similar in 25(OH)Ddeficient subjects with or without PTH elevation, both in the duodenum and PBMC. The PBMC VDRmRNA expression showed no significant change after cholecalciferol supplementation. A weak correlation coefficient between duodenal mucosa and PBMC VDRmRNA suggests that caution needs to be exercised while using the latter as a surrogate for other sites.
Introduction
Vitamin D deficiency (VDD) is observed in up to 90% of Asian Indians (Goswami et al., 2000; Vupputuri et al., 2006) and is equally prevalent in several other countries (Holick, 2006; Thacher et al., 2006) . Though the rise in serum PTH is a well-characterized bio-adaptive response in VDD (Fraser et al., 1967) , a majority of volunteers with chronic VDD have normal PTH values (Goswami et al., 2000) . Vitamin D and its metabolites act through vitamin D receptor (VDR) and the latter promotes transcription of calbindin-9k and calcium transporter TVRP6 genes (Ramasamy, 2006) . TVRP6 enhances transport of calcium across the enterocytes and intracellular calbindin maintains a gradient for the movement of calcium from the lumen to the cytoplasm of the enterocytes. An increase in VDR expression in duodenal mucosa would help in calcium homeostasis and could be another level of bio-adaptation in VDD. However, there is no study on the effect of VDD on VDRmRNA expression and its change following vitamin D supplementation in humans.
Subjects and methods
We assessed VDRmRNA expression by real time PCR in duodenal mucosa and in PBMC (peripheral blood mononuclear cells) in 45 subjects who underwent duodenoscopy for dyspeptic symptoms but had normal findings and in PBMC alone in a group of 48 healthy volunteers. None of the volunteers were on vitamin D and calcium supplementation.
A blood sample was drawn under fasting conditions for serum total calcium (albumin-adjusted), inorganic phosphorus, alkaline phosphatase, albumin, 25(OH)D and intact(i) PTH. The biochemical assays were performed in duplicates using Roche kits and semi-automated analyzer (Hitachi 4020; Boehringer, Germany). Normal range (NR) and intra-assay and inter-assay coefficients of variation (CV) for serum calcium, phosphorus and alkaline phosphatase were: 2.1-2.6 mmol/l, 0.80-1.45 mmol/l and o840 IU up to 18 years and o280 IU for 418 years of age, respectively, and 3.6, 3.8 and 3.5, 4.8 and 5.2 4.1%, respectively. Serum iPTH (NR ¼ 13-54 ng/l, intra-assay and inter-assay CV of 4 and 8%, respectively) and 25(OH)D were measured by an immunoradiometric assay and radio-immunoassay (Diasorin, Stillwater, MN, USA). Vitamin D status was defined as deficient, insufficient or sufficient based on serum 25(OH)D concentrations (Hollis, 2005) . Volunteers were grouped as I (n ¼ 25) if serum 25(OH)D was o50 nmol/l and iPTH 454 ng/l; group II if 25(OH)D was o50 nmol/l and iPTH p54 ng/l (n ¼ 68). Group III (n ¼ 23) was a subset of healthy volunteers in whom serum 25(OH)D, intact PTH and VDR-mRNA expression was reassessed in PBMC after eight weeks of oral cholecalciferol (60 000 IU/week) and calcium carbonate (1 gm elemental calcium daily). Institutional ethics committee approved the study protocol and written informed consent was obtained from all subjects.
The VDRmRNA and GAPDH expression was assessed by real time PCR using respective gene-specific primers (VDR: sense, 5 0 -gacatcggcatgatgaagg-3 0 and antisense, 5 0 -ctagggtcac agaagggtcatc-3 0 and GAPDH: sense, 5 0 -ccaaggtcatccatgacaa ctttggt-3 0 and antisense, 5 0 -tgttgaagtcagaggagaccacctg-3 0 ). Briefly, total RNA was purified from duodenal mucosal biopsy tissue and PBMC (separated by Ficoll) using RNAbinding columns (Eppendorf-AG, Germany) and 2 mg was reverse transcribed using random hexamer nucleotides and M-MuLv reverse transcriptase in a 20-ml reaction (42 1C for 1 h). The VDR mRNA copy numbers were measured in relation to GAPDH mRNA by amplifying VDR and GAPDH cDNA in separate tubes using SYBR-I dye (Sigma, USA) florescence signals on RT-PCR (iCycler, Biorad) (Mondal et al., 2006) . The conditions for PCR were initial denaturation at 94 1C 
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by post-PCR melting curve analysis and agarose gel electrophoresis (403 bp for VDR and 381 bp for GAPDH). The interassay and intra-assay coefficients of variation for cycle threshold were 2.0-3.0% for both VDR and GAPDH.
Statistical analysis
Data are shown as mean and standard deviations. Analysis of variance followed by post hoc Bonferroni test was used to compare differences in the various indices in the three study groups. Paired t-test was also used to compare indices before and after vitamin D supplementation in group III. Pearson's correlation coefficient was estimated between the VDRmRNA expressions in duodenum and PBMC; and also between 25(OH)D and PTH.
Results
The 25(OH)D status of the 93 study volunteers was similar to that described in our early studies (Goswami et al., 2000) . The mean 25(OH)D value was only 17.2 ± 8.2 nmol/l and showed an inverse correlation with iPTH (r ¼ À0.336, P ¼ 0.001). Twenty-five of total 93 (26.8%) volunteers (11 (24.4%) of 45 volunteers who underwent duodenoscopy and 14 (29.2%) of 48 volunteers) had supra-normal serum iPTH values. VDRmRNA expression was 13-fold more at duodenum than in PBMC (494±293 vs 38±22 copies per 10 6 GAPDG mRNA copies, Po0.001). The expression at two sites showed a weak correlation (r ¼ 0.42, P ¼ 0.003, Figure 1a ). VDRmRNA expression in the duodenum and PBMC showed no significant relationship with baseline 25(OH)D levels (r ¼ 0.123, P ¼ 0.42 and r ¼ À0.04, P ¼ 0.71, respectively). VDRmRNA expression at both the sites was comparable between groups I and II (Table 1) (Figure 1b) . These cut-off values of 25(OH)D were also validated in the linear regression analysis, which showed that there was a significant rise in PTH at the 25(OH)D level of 10-14 nmol/l. However, there were no significant differences in the PTH levels when the volunteers with serum 25(OH)D values 425 nmol/l were analyzed separately. Accordingly, when analyzed with these cut-off values, it was observed that there was no significant difference in the VDR mRNA copies either in the duodenum mucosal tissue (465±274 (n ¼ 31) vs 558±335 (n ¼ 14), P ¼ 0.33) and PBMC (50 ± 36 (n ¼ 77) vs 48 ± 27 (n ¼ 39), P ¼ 0.73) in the two groups (25(OH)D p25.0 and 425.0 nmol/l respectively). Similar stratification of the whole group at serum 25(OH)D cut-off of 12.23 nmol/l also revealed no significant difference in the VDR copy number, either in the duodenum or PBMC in the two groups.
After oral cholecalciferol supplementation for eight weeks, though the mean serum 25(OH)D levels increased (13.2 ± 2.2-85.9±17.5 nmol/l, Po0.001) and PTH levels decreased (54.3 ± 40.1-26.7 ± 14.4 ng/l, P ¼ 0.002), there was no significant change in VDRmRNA expression in the PBMC (46 ± 29 vs 47±28 copies 10 6 -GAPDH mRNA copies, P ¼ 0.90).
Discussion
The results of the current study showed no significant relationship between 25(OH)D levels and VDR expression in the duodenum and PBMC tissues in different grades of VDD, that is, with and without PTH elevation and in the absence of significant change following vitamin D supplementation. This indicates a lack of a role of changes in VDR expression as a bio-adaptive mechanism in hypovitaminotic D state. Interestingly, the present study also showed that despite an apparent relationship between VDR expression in duodenum and PBMC in humans, the correlation coefficient was weak. This suggests that caution needs to be exercised while using PBMC VDRmRNA expression as a surrogate for other sites. In this regard, the data on VDR expression in the duodenal tissue in VDD are directly relevant to the understanding of the patho-physiology of VDD in humans.
